Formulation and Drug Delivery, Parenterals

Mylan issued a voluntary withdrawal of calcium chloride intravenous infusion 10% w/v 10mL prefilled syringe due to difficulties in administration.

Two companies have been fined a total of GBP550,000 for faulty insulin syringes, which contained no drug and caused the death of a diabetic patient.

The agency clarifies its requirements for allowable excess volume and labeled vial fill size in injectables and biologics.

Hospira issued a voluntary worldwide recall due to confirmed subpotency and elevated impurity levels.

Merck KGaA fill-finish expansion in Italy will be completed in 2017.

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.

A Q&A with SCHOTT Pharmaceutical Systems and West Pharmaceutical Services

Using an alternate moisture-generation method may provide more accurate data for regulatory submissions.

A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.

Vetter held a groundbreaking ceremony for its new facility in Ravensburg.

How to maintain product stability and prevent particulates.

In new disposables projects, it is critical that engineering, procurement, and operations groups work together early on to manage supply chain risk.

Set limits to provide incentives for process improvements.

Resolve confusion about measurements.